Oral Lichen PlanusPhase 2NCT02453503
Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
A Phase 2 study testing Licorice and Triamcinolone Acetonide in people with Oral Lichen Planus, run by Isfahan University of Medical Sciences.
Trial summary
Introduction :Oral lichen planus (OLP) is one of the most common disorders of the oral cavity which is basically a chronic and inflammated mucocutaneous .There is no cure for OLP currently. The main focus of treatment is to reduce the duration and severity of the symptoms. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Oral Lichen Planus
- What is being tested?
- Licorice and Triamcinolone Acetonide
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- Jan 2014to Apr 2015
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- All patients over 18 years old
- All non pregnant women
Who cannot join
- -
About this study
Official title: Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on the Duration and Symptoms of Lesions That Caused by Symptomatic Oral Lichen Planus
Introduction :Oral lichen planus (OLP) is one of the most common disorders of the oral cavity which is basically a chronic and inflammated mucocutaneous .There is no cure for OLP currently. The main focus of treatment is to reduce the duration and severity of the symptoms. This study was designed to determine and compare the parameters of improvement in patient symptoms and lesions caused by oral lichen planus by using triamcinolone acetonide mucoadhesive film and licorice mucoadhesive film.
Methods and materials :The study was randomized by double-blind clinical trial . Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily. The patients were divided into two groups that were including 30 samples in each group. The first group was treated with triamcinolone mucoadhesive film and the second group were treated with licorice mucoadhesive film. Data were analyzed by using the Mann-Whitney test and t-test in SPSS software.
Read the detailed description
Introduction OLP is a chronic and inflammatory disease that frequently involves the oral mucosa. Clinical symptoms of OLP are various from white keratotic lesions without pain to erosion and painful injury (1). OLP episodic symptoms range from pain and irritation of the mouth that can affect the normal function and causes physical and mental pressure to patients.OLP can be seen in two main forms of reticular and erosive. Erosive OLP have been seen as injured Arytmatozo that enclosed by keratotic striae .These lesions are often follow by episodic symptoms of pain and irritation to severe discomfort and can cause a major negative impact on performance of oral system and l quality of life .So, being aware of the Clinical symptoms and management of these lesions are very important for the clinician. (4,3,2,1)
Although, these lesions rarely are life-threatening , discomfort and pain associated with abnormal caloric intake lead to nervosa, dehydrated in short order and malnutrition. It also increases the risk of infection and reduce the quality of life in patients greatly.(2,3). The main treatment for symptomatic OLP is prescribing systemic or topical corticosteroids . (1,3) and its strong type like triamcinolone has been increasingly used in the treatment of OLP (4).
Lichen planus is a chronic mucocutaneous disease and relatively common in middle-aged that affected 2- 0.2% of the population. Men and women are almost equally affected. In the mouth, white bilatera lesions sometimes cause wound The most common clinical pattern is linear (9-5) .There is a limited study in the frequency and clinical forms of OLP.
It can be mention to Esmaeili etal study that patients in men and in fourth decades is most common and Hypertrophic and classic type are more and the type of reticular in oral lesions is more prevalent (10)and in another study by Khalili etal reported that the most common form of clinical lesion is ulcerated lesion and the average time spend 18.4 months, most commonly involving mucosa is the buccal and then the tongue and gums .White spots, lines Wickham and mucosal erythema are the most common clinical features of the lesion (11).
There is currently no cure for OLP. The main focus of treatment is to reduce the duration and severity of symptoms. The most common and acceptable treatment for symptomatic OLP lesions and systemic corticosteroids or topical is to modulate the host immune response .In mild to moderate lesions the main treatment is by topical corticosteroids such as clobetasol gel, betamethasone gel and triamcinolone ointment (2, 3, 12). Due to the persistence of the drug at the site of the lesion may be used new dosage form of mucoadhesive such as tablets or film. Films are from mucoadhesive drug delivery systems that have been used in the manufacture of mucoadhesive polymers and have received considerable attention in recent years .The films can be attached on the oral wound healing and cause to reduce pain and inflammatory diseases. (4, 13)
The Licorice plant have been used in traditional medicine for the treatment of aphthous ulcers, gastric ulcers, hepatitis C, cough, Asthma, Addison and skin diseases. Clinical pharmacology studies have shown that this herb also contains beneficial anti-inflammatory components, antiviral and antibacterial, antioxidant, anticancer and modifying the immune system is .Licorice contains a provision, glycyrrhetinic acid and glycyrrhizin which helps in healing wounds (14,15,16) In 2008, Martin et al. examined the effects of oral patch containing licorice extract (Licorice) for the treatment of aphthous ulcers and found positive effects on the size of the lesion and the patient's report of pain. (15) Chan et al., investigated palliative treatment of patients with symptomatic OLP such as steroids, Cyclosporine and topical retinoid in a systematic review and concluded that there are only weak evidence for the superiority of this treatment compared with placebo . The authors also expressed several studies has been faced with restrictions in which various compounds with potentially useful results on the OLP.
Conducted studies were not enough strong , the control group was small, making blind about the researcher or patient didn't do in them or have been made errors in designing the study. There would be special need to statistically powerful studies in order to determine the value of new compounds in the prevention or treatment of mucositis .(17)
The purpose of this study is to find a way to reduce pain and inflammation in patients with symptomatic OLP On the one hand and reduce the risk of infection, reduce the need for pain medication and ultimately improve the quality of life by using triamcinolone mucoadhesive films or licorice in this group of patients.
Methods and materials:
This study was a clinical trial and randomized as double-blind. Sampling was done randomly Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily.. In this study, patients with symptomatic OLP over 18 years both men and non-pregnant women enrolled in the study and . All patients were examined for dental Prophylaxis and oral hygiene and recommendations about compliance with oral health have been done for all patients . After filling written consent , the patients were divided into two groups randomly :first group I (n = 30) will be treated with triamcinolone Mucoadhesive film and the second group (n = 30) will be treated with licorice mucoadhesive film.
All patients underwent a complete dental examination and diagnosis of patients with oral lichen planus lesions initially marked by physical examination and conducted by interviewing with patients and then confirmed by histologic evaluation .The duration of treatment or recovery of lesions was two weeks as the weekly visits.
The Triamcinolone Mucoadhesive film with 1 mg was prepared and provided to patients in one group. And another group was given licorice mucoadhesive film by Afnogel brand name .The drug dose was determined three times a day after meals and before bed time that patients put it in the upper part of gum after eating and washing mouth and the patient can do common function like talking and eating and drinking within releasing the drug.
Severity and recovery rate of lesions were measured in each visit in accordance with the criteria that set in Buajeeb etal(18) from 0 to 5 degrees .The rate of pain in patients that created by Mucositis assessed by ruler and VAS method and it was given a number from 0 to 10 according to the rate of pain.
Injury or burning ,pain on waking, eating, drinking, talking, pain when swallowing, dry mouth, tingling or numbness after taking the studied medication and using the products containing caffeine, tobacco, and alcohol in the questionnaire registered by the patient .The compliance of patients were evaluated based on the returned mucoadhesive at the end of each week and based on the number of patients' visits to physicians. The patient withdrew from the study for any reason, pregnancy, drug interactions, compliance less than 70% patients about taking the medicine o has been done by referring to the doctor .All of the cases were collected and analyzed by the Mann-Whitney test.
- Conditions
- Oral Lichen Planus
- Being tested
- Licorice, Triamcinolone Acetonide
- Keywords
- Lichen planus, Mucoadhesive film, licorice
- Medical subject headings
- Lichen Planus, Oral, Lichen Planus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LicoriceDrug
Also called Aftogel
licorice mucoadhesive films evey 6 hours for two weeks
Triamcinolone AcetonideDrug
Also called Triamcinolone
Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks.
| Study group | Role | What they receive |
|---|---|---|
| Triamcinolone acetonide | Active comparator | Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks. Receives: Drug: Triamcinolone Acetonide |
| Licorice | Experimental | Licorice mucoadhesive films 1 mg every 6 hours for two weeks. Receives: Drug: Licorice |
What is being measured
The primary outcome is the main question the study is designed to answer.
VAS
Pain severity was measured by visual analogue scale : 0 for no pain and 10 for most painful experience
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2015 (estimated)
- Study startJan 2014
- Primary completionMar 2015
- Study completionApr 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Oral Lichen PlanusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Isfahan University of Medical Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehdi Nasr Isfahani, Isfahan University of Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02453503
- Sponsor's protocol ID
- 394115
- Status last verified
- May 2015
- First submitted
- 15 May 2015
- Last updated
- 25 May 2015
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on the Duration and Symptoms of Lesions That Caused by Symptomatic Oral Lichen Planus
- ClinicalTrials.gov ID
- NCT02453503
- Acronym / sponsor ID
- 394115
- Conditions
- Oral Lichen Planus
- Keywords
- Lichen planus, Mucoadhesive film, licorice
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Isfahan University of Medical SciencesUniversity, hospital or other
- Study start
- Jan 2014
- Primary completion
- Mar 2015 (actual)
- Study completion
- Apr 2015 (actual)
- First posted
- 25 May 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction :Oral lichen planus (OLP) is one of the most common disorders of the oral cavity which is basically a chronic and inflammated mucocutaneous .There is no cure for OLP currently. The main focus of treatment is to reduce the duration and severity of the symptoms. This study was designed to determine and compare the parameters of improvement in patient symptoms and lesions caused by oral lichen planus by using triamcinolone acetonide mucoadhesive film and licorice mucoadhesive film.
Methods and materials :The study was randomized by double-blind clinical trial . Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily. The patients were divided into two groups that were including 30 samples in each group. The first group was treated with triamcinolone mucoadhesive film and the second group were treated with licorice mucoadhesive film. Data were analyzed by using the Mann-Whitney test and t-test in SPSS software.
Detailed description
Introduction OLP is a chronic and inflammatory disease that frequently involves the oral mucosa. Clinical symptoms of OLP are various from white keratotic lesions without pain to erosion and painful injury (1). OLP episodic symptoms range from pain and irritation of the mouth that can affect the normal function and causes physical and mental pressure to patients.OLP can be seen in two main forms of reticular and erosive. Erosive OLP have been seen as injured Arytmatozo that enclosed by keratotic striae .These lesions are often follow by episodic symptoms of pain and irritation to severe discomfort and can cause a major negative impact on performance of oral system and l quality of life .So, being aware of the Clinical symptoms and management of these lesions are very important for the clinician. (4,3,2,1)
Although, these lesions rarely are life-threatening , discomfort and pain associated with abnormal caloric intake lead to nervosa, dehydrated in short order and malnutrition. It also increases the risk of infection and reduce the quality of life in patients greatly.(2,3). The main treatment for symptomatic OLP is prescribing systemic or topical corticosteroids . (1,3) and its strong type like triamcinolone has been increasingly used in the treatment of OLP (4).
Lichen planus is a chronic mucocutaneous disease and relatively common in middle-aged that affected 2- 0.2% of the population. Men and women are almost equally affected. In the mouth, white bilatera lesions sometimes cause wound The most common clinical pattern is linear (9-5) .There is a limited study in the frequency and clinical forms of OLP.
It can be mention to Esmaeili etal study that patients in men and in fourth decades is most common and Hypertrophic and classic type are more and the type of reticular in oral lesions is more prevalent (10)and in another study by Khalili etal reported that the most common form of clinical lesion is ulcerated lesion and the average time spend 18.4 months, most commonly involving mucosa is the buccal and then the tongue and gums .White spots, lines Wickham and mucosal erythema are the most common clinical features of the lesion (11).
There is currently no cure for OLP. The main focus of treatment is to reduce the duration and severity of symptoms. The most common and acceptable treatment for symptomatic OLP lesions and systemic corticosteroids or topical is to modulate the host immune response .In mild to moderate lesions the main treatment is by topical corticosteroids such as clobetasol gel, betamethasone gel and triamcinolone ointment (2, 3, 12). Due to the persistence of the drug at the site of the lesion may be used new dosage form of mucoadhesive such as tablets or film. Films are from mucoadhesive drug delivery systems that have been used in the manufacture of mucoadhesive polymers and have received considerable attention in recent years .The films can be attached on the oral wound healing and cause to reduce pain and inflammatory diseases. (4, 13)
The Licorice plant have been used in traditional medicine for the treatment of aphthous ulcers, gastric ulcers, hepatitis C, cough, Asthma, Addison and skin diseases. Clinical pharmacology studies have shown that this herb also contains beneficial anti-inflammatory components, antiviral and antibacterial, antioxidant, anticancer and modifying the immune system is .Licorice contains a provision, glycyrrhetinic acid and glycyrrhizin which helps in healing wounds (14,15,16) In 2008, Martin et al. examined the effects of oral patch containing licorice extract (Licorice) for the treatment of aphthous ulcers and found positive effects on the size of the lesion and the patient's report of pain. (15) Chan et al., investigated palliative treatment of patients with symptomatic OLP such as steroids, Cyclosporine and topical retinoid in a systematic review and concluded that there are only weak evidence for the superiority of this treatment compared with placebo . The authors also expressed several studies has been faced with restrictions in which various compounds with potentially useful results on the OLP.
Conducted studies were not enough strong , the control group was small, making blind about the researcher or patient didn't do in them or have been made errors in designing the study. There would be special need to statistically powerful studies in order to determine the value of new compounds in the prevention or treatment of mucositis .(17)
The purpose of this study is to find a way to reduce pain and inflammation in patients with symptomatic OLP On the one hand and reduce the risk of infection, reduce the need for pain medication and ultimately improve the quality of life by using triamcinolone mucoadhesive films or licorice in this group of patients.
Methods and materials:
This study was a clinical trial and randomized as double-blind. Sampling was done randomly Patients with symptomatic OLP who referred to the Oral Medicine School of Dentistryin Medical Sciences in Isfahan University participated voluntarily.. In this study, patients with symptomatic OLP over 18 years both men and non-pregnant women enrolled in the study and . All patients were examined for dental Prophylaxis and oral hygiene and recommendations about compliance with oral health have been done for all patients . After filling written consent , the patients were divided into two groups randomly :first group I (n = 30) will be treated with triamcinolone Mucoadhesive film and the second group (n = 30) will be treated with licorice mucoadhesive film.
All patients underwent a complete dental examination and diagnosis of patients with oral lichen planus lesions initially marked by physical examination and conducted by interviewing with patients and then confirmed by histologic evaluation .The duration of treatment or recovery of lesions was two weeks as the weekly visits.
The Triamcinolone Mucoadhesive film with 1 mg was prepared and provided to patients in one group. And another group was given licorice mucoadhesive film by Afnogel brand name .The drug dose was determined three times a day after meals and before bed time that patients put it in the upper part of gum after eating and washing mouth and the patient can do common function like talking and eating and drinking within releasing the drug.
Severity and recovery rate of lesions were measured in each visit in accordance with the criteria that set in Buajeeb etal(18) from 0 to 5 degrees .The rate of pain in patients that created by Mucositis assessed by ruler and VAS method and it was given a number from 0 to 10 according to the rate of pain.
Injury or burning ,pain on waking, eating, drinking, talking, pain when swallowing, dry mouth, tingling or numbness after taking the studied medication and using the products containing caffeine, tobacco, and alcohol in the questionnaire registered by the patient .The compliance of patients were evaluated based on the returned mucoadhesive at the end of each week and based on the number of patients' visits to physicians. The patient withdrew from the study for any reason, pregnancy, drug interactions, compliance less than 70% patients about taking the medicine o has been done by referring to the doctor .All of the cases were collected and analyzed by the Mann-Whitney test.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Triamcinolone acetonide | Active comparator | Drug: Triamcinolone AcetonideTriamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks. |
| Licorice | Experimental | Drug: LicoriceLicorice mucoadhesive films 1 mg every 6 hours for two weeks. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All patients over 18 years old
- All non pregnant women
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LicoriceAlso: Aftogellicorice mucoadhesive films evey 6 hours for two weeks | Drug | Licorice |
| Triamcinolone AcetonideAlso: TriamcinoloneTriamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks. | Drug | Triamcinolone acetonide |
Primary outcome
VAS
Time frame: 12 months
Pain severity was measured by visual analogue scale : 0 for no pain and 10 for most painful experience
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2015.
Related trials for Oral Lichen Planus
RecruitingObservational study
Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers
Oral Potentially Malignant Disorders, Oral Lichen Planus
Not yet recruiting
Curcumin-mediated Photodynamic Therapy Versus Photobiomodulation in the Treatment of Oral Erosive Lichen Planus
Oral Lichen Planus
Not yet recruiting
Adherence to Topical and Systemic Medications Among Symptomatic Oral Lichen Planus Patients: A Pilot Randomized Clinical Trial
Degree of Adherence of Symptomatic OLP Patients to Their Medications
Active, not recruitingPhase 4
Low Level Laser Therapy With Injectable Platelet Rich Fibrin in Management of Oral Lichen Planus
Oral Lichen Planus
Active, not recruiting
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
Erythroplakia, Fanconi Anemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Licorice and Triamcinolone Acetonide in people with Oral Lichen Planus, run by Isfahan University of Medical Sciences.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 May 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VAS (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2015.